Australians using an inhaled corticosteroid for asthma are almost twice as likely as New Zealanders to take it in combination with a long-acting beta agonist but disease control is equally poor in both countries, new research has shown. The study from the Woolcock Institute found that 61% of Australians used an ICS-containing inhaler compared to ...
ICS/LABA combination dominates Australian asthma treatment
By Tony James
11 Aug 2017